Compare · ALC vs WRBY
ALC vs WRBY
Side-by-side comparison of Alcon Inc. (ALC) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALC and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- ALC is the larger of the two at $33.27B, about 10.9x WRBY ($3.04B).
- Both names hit the wire about 3 times in the past 4 weeks.
- Both have 25 recent analyst ratings on file.
- Company
- Alcon Inc.
- Warby Parker Inc.
- Price
- -
- -
- Market cap
- $33.27B
- $3.04B
- 1M return
- +1.52%
- -
- 1Y return
- -11.87%
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- 2021
- News (4w)
- 3
- 3
- Recent ratings
- 25
- 25
Alcon Inc.
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest ALC
- FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
- Barclays initiated coverage on Alcon with a new price target
- Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
- Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
- Alcon Prices EUR 500 Million Senior Notes Offering
- Alcon downgraded by BNP Paribas Exane with a new price target
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
- SEC Form SD filed by Alcon Inc.
Latest WRBY
- Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026
- Director Raider Jeffrey Jacob sold $415,500 worth of shares (15,000 units at $27.70) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 420,201 units (SEC Form 4)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 95,614 shares and sold $2,769,000 worth of shares (100,000 units at $27.69) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 36,020 units (SEC Form 4)
- Warby Parker Announces Participation in the Goldman Sachs 33rd Annual Global Retailing Conference
- Co-Chief Executive Officer Gilboa David Abraham covered exercise/tax liability with 11,504 shares and converted options into 20,798 shares, increasing direct ownership by 30% to 40,406 units (SEC Form 4) (tax liability)
- Co-Chief Executive Officer Blumenthal Neil Harris covered exercise/tax liability with 11,504 shares and converted options into 20,798 shares, increasing direct ownership by 30% to 40,406 units (SEC Form 4) to cover taxes
- SEC Form 10-Q filed by Warby Parker Inc.
- Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Warby Parker Announces Second Quarter 2026 Results
- Warby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026